04/07/2015 21:41:03 Cookie Policy Free Membership Login

Alliance Pharma Share Chat - APH

Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change Price Change % Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00 +0.00% 42.25 41.50 43.00 42.25 42.00 42.25 699,459 11:16:41
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 43.5 10.2 3.2 13.3 111.62

Alliance Pharma Share Discussion Threads

Showing 1175 to 1200 of 1200 messages
Chat Pages: 48  47  46  45  44  43  42  41  40  39  38  37  >>
Riv As a long term shareholder and accumulator on the dips I think you have made a good purchase with a suitable medium / long term timeframe.norbert colon
I picked some of these up on the dip at just above 38p, so going pretty well to date. I liked the look of the company when I saw them present a while back. Should be a nice solid long-termer, with room for sudden jumps in forecasts and the share price on further company or product acquisitions.rivaldo
Is something 'cooking' here, as there have been a series of steady buy's going through over the last few days that's suggesting someone, somewhere is in the know....? May have some connection to my Post 552mazarin
Interactive's comment on Clifford's maiden buy : http://tinyurl.com/nwpaodvmazarin
http://www.fool.co.uk/investing/2015/06/18/is-alliance-pharma-plc-the-perfect-partner-for-astrazeneca-plc-in-your-portfolio/norbert colon
Maz Noted and personally I see a sub 40p offer as a very good entry point for any new investors. I already have a lot but will be tempted to add further if the price from Mr Market get down to sub 35p. Steady as she goes.norbert colon
I see that yesterday's RNS re PMDR purchase is timely as today APH went ex-dividend and represented Nigel Clifford's first buy since he was appointed at the beginning of the year. A glaring omission IMO as noted in February in Post 527.mazarin
My key take-aways from this week's AGM in no particular order: 1) Now that the mcap is >GBP 100m they are likely to start attracting interest from funds / institutions, some of which can only invest in companies >GBP 100m mcap. 2) Current major shareholders are very supportive of the company and understand that there have been short term head winds but the company is now coming out the other side in a positive way. 3)Still early days for Lypsyl / A&P powders although some TV marketing underway in the Midlands. No specific targets for revenue / growth yet. 4) They want to expand globally with a move into Spain / Italy very likely (as they have recently done in Germany / France). They see Europe as a key growth area along with the USA and China. Tony Booley was in China at the time of the AGM. 5) There are other competitors in the same space as them including some US firms looking to move into the UK market. APH typically benefit from their strong reputation and ability to transact confidently and quickly. 6) They are constantly on the look-out for deals / acquisitions but they need to be right. As Mazarin noted above, they missed out on a significant acquisition last year and I would expect their record of 1-3 deals a year to continue. Very few questions from shareholders which to me is testament to their management and the fact they have a strong, reputable and profitable business with very limited operational risk and s measured approach to growth. The AGM statement covered other key topics such as news on Immucyst and the need for a new FD. For me APH will remain a very long term hold in my SIPP. Good luck to all.norbert colon
I believe the final extract from the latest statement is worth a mention..... "We have a strong pipeline of potential acquisition opportunities and have more than £20 million of undrawn bank facilities available to us" APH narrowly missed out on sealing a significant acquisition last year and IMO are unlikely to let the same thing happening this year. So watch this space...!mazarin
I'm taking a look at the moment. Currently in CTP/MXCP/TEK and the Slater/Wray interest brought me here.treeshake
Good to see APH putting in another leg up. Very quiet on this board. Wonder if the break-out will put this on a few more people's radars.pimpernel4
Top 20 Major Investors as of 09/03/15 Director & Related 64,277,893 24.33% Nigel Wray 40,676,510 15.40% MVM Life Science Partners 24,061,900 9.11% Aviva Investors Global Services 22,762,309 8.62% Artemis Fund Managers Ltd 17,305,304 6.55% Slater Investments 10,297,038 3.90% LGT Capital Management 9,861,391 3.73% Brown Shipley Asset Management 9,747,373 3.69% Cavendish Asset Management 7,929,000 3.00% BlackRock Investment Management (UK) 6,087,463 2.30% Redmayne Bentley Stockbroker 3,366,528 1.27% Brooks Macdonald Asset M'mnt 3,324,237 1.26% Barclays Wealth Management (UK) 2,882,590 1.09% WH Ireland 2,864,160 1.08% TD Direct Investing 2,344,172 0.89% Hargreave Hale 2,231,000 0.84% Hargreaves Lansdown Asset M'mnt 2,128,706 0.81% NCL Smith & Williamson Inv'mnt 2,071,666 0.78% As at 9th March 2015 I'm surprised to see that the Company was essentially held by only 819 shareholders in total with : 264,162,665 shares in issue.mazarin
Aim Trader - thanks for presentation - very useful and highlights very clearly what a great business this is. A lot of investors just don't have the patience to let the value materialise with some of these companies. I look forward to the AGM on 27th May and news of further deals.norbert colon
Looks like we are heading firmly into a new, higher trading range.pimpernel4
To view Alliane Pharma's presentation from last night’s Proactive Investors One2One Investor Forum, click on the following link: http://tinyurl.com/owt96bvaim_trader
hxxp://www.alliancepharma.co.uk/alliance/dlibrary/panda/2015-Notice%20Artwork.pdf 10am in London (Buchanan's)norbert colon
AGM on 27 May, I see. Where and at what time?123prezzie
I have been buying APH at typically around 32p (between 25p-35p anyway) since Nov 2011 and have had comments from a few investors that they like the company, buy shares and then sell them because they lose interest and / or the SP is flatlining. I am pleased my conviction and patience seems to be starting to pay off and look forward to attending the AGM for the first time this year, having perviously been overseas or otherwise unavailable. I very much look forward to this being a core holding of mine for many years.norbert colon
Today's Hardman report on Alliance Pharma clearly falling on receptive ears. hxxp://www.hardmanandco.com/sites/default/files/research_papers/Alliance%20Pharma%20Finals%20-%2013%20April%202015_Final.pdfpimpernel4
CEO John Dawson to present on 23rd April at the Chesterfield Mayfair. Click here to register; http://tinyurl.com/ndxk35eaim_trader
Pimpernel Interesting share price movement over recent weeks and really pleased that I added to my holding at the end of March. Did not expect the strong move but have been holding / buying for a number of years now at the low 30's where I could. I really think 2015/2016 is going to be very strong for APH and await further news in anticipation. Good luck to all.norbert colon
Seems to be a buyer around, 100k taken at 40.1pimpernel4
First buys coming in above 40 at 40.5ppimpernel4
40p to buy at close there. Go APH. Bodes well.pimpernel4
Chat Pages: 48  47  46  45  44  43  42  41  40  39  38  37  >>

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 150704 21:41